Opus Genetics, Inc. (IRD) insider trading

By person

27 insiders · 60 transactions

13.3×

Dr. George Magrath holds 13.3 times base salary in stock. $7.99M of shares against $598.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Dr. George Magrath last reported holding, valued at $3.90, the price Common Stock was last bought or sold at on the open market here, on 3 Nov 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Foundation Fighting Blindness Retinal Degeneration Fund entity

Director

—

$18.75M (3)

−$18.75M

3,236,171

3.89%

$12.62M

+26.2%

Cam Gallagher

Director

$323.69K (3)

—

+$323.69K

2,966,111

3.57%

$11.57M

+3,474%

Robert E. Gagnon

Chief Financial Officer

—

$240.46K (4)

−$240.46K

542,375

0.6519%

$2.11M

—

Chang Ho Ahn

Director

—

$175.38K (1) scheduled

−$175.38K

6,510,000

7.82%

$25.38M

0.0%

Benjamin R Yerxa

President

$9.83K (1)

$178.55K (4)

−$168.72K

670,917

0.8064%

$2.62M

—

George Magrath

Chief Executive Officer

$256.58K (5)

$349.47K (5)

−$92.89K

2,010,636

2.42%

$7.84M

—

Susan Benton

Director

$91.40K (1)

—

+$91.40K

243,894

0.2932%

$950.99K

—

Jay Pepose

Director

$90.11K (2)

—

+$90.11K

180,458

0.2169%

$703.64K

+8,440%

Joseph K Schachle

Chief Operating Officer

$4.10K (1)

$74.69K (4)

−$70.59K

286,673

0.3446%

$1.12M

—

Ashwath Jayagopal

Chief Scientific & Dev. Ofc.

$6.18K (1)

$58.20K (2)

−$52.02K

509,233

0.6121%

$1.99M

—

Mina Sooch

President and CEO

$51.18K (3)

—

+$51.18K

430,501

0.5175%

$1.68M

—

Douglas J Swirsky

President and CEO

$31.72K (1)

—

+$31.72K

50,000

0.0601%

$194.96K

—

Rabourn Amy Zaremba

Head of Fin. Quality Assurance

—

$23.31K (2)

−$23.31K

188,671

0.2268%

$735.67K

—

Nirav S. Jhaveri

Chief Financial Officer

$21.00K (1)

—

+$21.00K

194,293

0.2335%

$757.59K

—

James S J Manuso

Director

$16.95K (3)

—

+$16.95K

317,318

0.3814%

$1.24M

—

Lisa Nolan

Chief Business Officer

$12.96K (1)

—

+$12.96K

23,250

0.0279%

$90.66K

—

Ben Gil Price

Director

$9.14K (1)

—

+$9.14K

15,000

0.0180%

$58.49K

—

Charles Beever

Director

$6.38K (1)

—

+$6.38K

11,000

0.0132%

$42.89K

+1,000%

Sean Ainsworth

Director

— (1)

—

$0.00

321,692

0.3867%

$1.25M

—

Alan R Meyer

Director

— (1)

—

$0.00

487,029

0.5854%

$1.90M

—

Richard J Rodgers

Director

— (1)

—

$0.00

343,022

0.4123%

$1.34M

—

Jean Bennett

Director

—

259,019

0.3113%

$1.01M

—

Bernhard Hoffmann

SVP of Corp. Dev.

—

185,446

0.2229%

$723.09K

—

Adrienne L Graves

Director

—

127,514

0.1533%

$497.20K

—

Ronil A. Patel

Chief Business Officer

—

90,714

0.1090%

$353.71K

+306.7%

Peter David Suzdak

Chief Executive Officer

—

22,250

0.0267%

$86.76K

+270.8%

Ely Benaim

Chief Medical Officer

—

4,750

0.0057%

$18.52K

—

Opus Genetics, Inc.

What the insiders did Net selling

By person